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Abstract
Background:  Efforts to improve the efficiency of non-viral gene delivery require a better
understanding of delivery kinetics of DNA molecules into clinically relevant cells. Towards this goal,
three DNA molecules were employed to investigate the effects of DNA properties on cellular
delivery: a circular plasmid DNA (c-DNA), a linearized plasmid DNA (l-DNA) formulated by single-
site digestion of c-DNA, and smaller linear gene cassette generated by PCR (pcr-DNA). Four non-
viral gene carriers were investigated for DNA delivery: polyethyleneimine (PEI), poly-L-Lysine
(PLL), palmitic acid-grafted PLL (PLL-PA), and Lipofectamine-2000™. Particle formation, binding
and dissociation characteristics, and DNA uptake by rat bone marrow stromal cells were
investigated.
Results: For individual carriers, there was no discernible difference in the morphology of particles
formed as a result of carrier complexation with different DNA molecules. With PEI and PLL
carriers, no difference was observed in the binding interaction, dissociation characteristics, and
DNA uptake among the three DNA molecules. The presence of serum in cell culture media did
not significantly affect the DNA delivery by the polymeric carriers, unlike other lipophilic carriers.
Using PEI as the carrier, c-DNA was more effective for transgene expression as compared to its
linear equivalent (l-DNA) by using the reporter gene for Enhanced Green Fluorescent Protein. pcr-
DNA was the least effective despite being delivered into the cells to the same extent.
Conclusion: We conclude that the nature of gene carriers was the primary determinant of cellular
delivery of DNA molecules, and circular form of the DNA was more effectively processed for
transgene expression.
Background
Non-viral delivery systems are being pursued to facilitate
therapeutic gene transfer in a clinical setting. Non-viral
carriers, such as cationic lipids and polymers, typically
interact with the anionic DNA via charged moieties, and
condense the long, string-like DNA molecules into com-
pact, nano-sized particles that are suitable for cellular
uptake [1,2]. A range of cationic lipids and polymers has
been engineered to accomplish this function effectively,
and intelligent carriers are being continually designed
with the purpose of controlling intracellular fate of DNA
molecules. Most studies on non-viral gene transfer were
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conducted with circular plasmid DNA (c-DNA), which is
known to be less susceptible to intracellular degradation.
Linearized forms of c-DNA (l-DNA) with similar molecu-
lar weight, as well as shorter l-DNA that bears only the
gene of interest and the promoter region have been used
in some studies [3-8]. A c-DNA exhibits a higher intracel-
lular diffusivity compared to its linearized forms [9],
which facilitates its nuclear targeting for more effective
expression. l-DNA is expected to be prone to nuclease
attack intracellularly, but its stability could be increased
by capping the 3' and 5' ends of the molecule with hairpin
structures [8]. Smaller l-DNA molecules, on the other
hand, displays better ability to traverse the nuclear mem-
brane, potentially contributing to better translation of the
transgene. Studies attempting to directly compare the effi-
ciency of different DNA molecules yielded conflicting
results. Whereas Cherng et al. observed better expression
of LacZ gene when cells were transfected with c-DNA [9],
Schakowski et al. observed a similar expression level
(based on % transfected cells) for the two DNA topologies
with both polymeric and lipid-based carriers [7]. A differ-
ence in the level of gene expression (based on IL-2 expres-
sion), however, was noted in the latter study, shorter l-
DNA giving enhanced expression [7]. In direct nuclear
injection studies, with no nuclear transport barriers to
DNA molecules, l-DNA yielded more effective gene
expression, suggesting an intrinsic superiority of l-DNA
for transcription [6]. Shorter l-DNA molecules with intact
promoter/gene regions were even more effective [6], pos-
sibly due to better assembly of transcriptional factors and/
or reduced non-specific interactions of proteins with the
DNA molecules. The nature of delivery vehicle appeared
to influence the transfection efficiency, l-DNA being more
sensitive to the choice of the carrier, unlike the c-DNA [8].
This was indicative of the differences in the transport effi-
ciency among the carriers, but no studies directly com-
pared the efficiency of cell delivery of different DNA
molecules.
This study investigated the non-viral delivery of 3 types of
DNA molecules (Figure 1), namely a c-DNA representing
a circular plasmid, a linearized version of the c-DNA after
restriction digest at a single site, and a shorter version of
the l-DNA amplified by a PCR reaction (pcr-DNA). Four
different non-viral carriers were utilized, including 2 cati-
onic polymers commonly used for DNA delivery, poly-
ethyleneimine (PEI) and poly-L-lysine (PLL), an in-house
synthesized palmitic acid-grafted PLL (PLL-PA) [10], and
the most-commonly used commercial lipid Lipo-
fectamine-2000™. By using combinations of different
DNA molecules and carriers, the influences of DNA
molecular weights and topologies on the delivery to bone
marrow stromal cells were investigated. These cells, unlike
commonly used immortal cells, are an important cell phe-
notype for clinical protocols. Finally, transgene expression
by the three DNA forms were investigated by using the
reporter gene Enhanced Green Fluorescent Protein
(EGFP). Our results indicated the delivery of all three
types of DNA molecules was equally effective for each car-
rier, with significant carrier-to-carrier differences in deliv-
ery rates, but c-DNA were more effective in yielding
reporter gene expression as compared to the linearized
DNA molecules.
Methods
Materials
Branched 25-kDa PEI, PLL (25 kDa), Hank's Balanced Salt
Solution (HBSS), trypsin/EDTA, and sodium salt of Amp-
icillin were obtained from SIGMA (St. Louis, MO).
Lipofectamine2000™ was purchased from Invitrogen
(Carlsbad, CA). Dulbecco's Modified Eagle Medium
(DMEM; high glucose with L-glutamine), Penicillin
(10,000 U/ml), and Streptomycin (10,000 µg/ml) were
from GIBCO (Grand Island, NY). Dialysis tubing with a
MW cut-off of 12-14 kDa was purchased from Spectrum
Laboratories (Gardena, CA). Fetal Bovine Serum (FBS)
was from Atlanta Biologicals (Lawrenceville, GA). A suc-
cinimide ester of Cy5.5 (Cy5.5-NHS) used for labeling
DNA was purchased from Amersham (Baie d'Urfé, QC).
PLL modified with palmitic acid was synthesized as previ-
ously described [10]. The plasmid gWiz-blank (5.1 kb),
which lacks EGFP, was obtained from Aldevron (Fargo,
ND).
Preparation of Different DNA Molecules (Figure 1)
Circular Plasmid DNA (c-DNA)
The plasmid, pORF9-hTNFRS11b (4272 bp) encoding the
human Osteoprotegerin gene, was purchased from Invi-
vogen (San Diego, CA) as transformed Escherichia coli fro-
zen culture. The plasmid, pEGFP-N2 (4737 bp),
incorporating an enhanced green fluorescent protein was
obtained from BD Biosciences. Cells were revitalized and
grown in 12 L of Luria-Bertani broth containing either 100
µg/mL of Ampicillin (pORF9-hTNFRS11b) or 50 µg/ml of
Kanamycin (pEGFP-N2) for 16 hours at 37°C with shak-
ing at 125 rpm. Cells were harvested and plasmid was
purified using QIAGEN Plasmid Giga Kit (Qiagen; Missis-
sauga, ON) as described in the manufacturer's handbook.
The purified plasmid was dissolved in ddH2O at a final
concentration of ~1.8 mg/mL. Concentration and purity
were determined by UV Spectroscopy using
NanoDrop1000 instrumentation.
Linear DNA (l-DNA)
Purified c-DNA was linearized using the restriction
enzyme, XhoI (New England Biolabs; Pickering, ON) for
pORF9-hTNFRS11b or ClaI (Invitrogen; Burlington, ON)
for pEGFP-N2, Restriction digestion were set up with 5 µg
of DNA per 50 µL of reaction volume containing 3 units
of enzyme and incubated at 37°C for 16 hours. TheBMC Biotechnology 2008, 8:23 http://www.biomedcentral.com/1472-6750/8/23
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enzyme was then heat-inactivated by incubating the mix-
ture at 65°C for 10 min. Digested DNA was purified using
QIAEX II Gel Extraction Kit (Qiagen, Mississauga, ON).
Purity of the isolated product was confirmed by spectro-
photometry and gel electrophoresis was used to confirm
the presence of a single band in the preparation.
Gene Cassette (pcr-DNA)
The primers, hOPG-F2 (5'-CGAAACAAAACAAACTAG-
CAAAAT-3') and hOPG-R2 (5'-CCTTTTGCTCACATGT-
TCTTAATTA-3') was used to synthesize gene cassette from
the plasmid pORF9-hTNFRS11b; GFP-F1 (5'-TCCTGCGT-
TATCCCCTGATT-3') and GFP-R1 (5'-CGCTTACAATT-
TACGCCTTAAG-3') was used to synthesis gene cassette
from the plasmid pEGFP-N2. All primers were customar-
ily designed and synthesized by IDT Technology
(Toronto, ON). Synthesis of gene cassette was carried out
using PCR in a 50 µL reaction containing 0.6 µM of each
of the primers, 0.2 mM dNTP, 1 unit of Platinum® Taq
DNA Polymerase High Fidelity (Invitrogen), 1× Hi Fi PCR
buffer, 1.5 mM of MgSO4, and 20 ng of c-DNA as the tem-
plate. Reaction parameters were as follows: 2 min at 94°C
followed by 35 cycles of 30 s at 94°C, 30 s at 60°C, and 3
min at 68°C, then an addition 5 min incubation at 68°C.
The PCR products so obtained were purified by QIAGEN
PCR purification kit (Qiagen, Mississauga, ON). Purity of
the isolated product was confirmed by spectrophotome-
try, and gel electrophoresis was used to confirm the pres-
ence of a single band in the preparation. The resulting
PCR product was approximately 2209 bp (pORF9-
hTNFRS11b) or 1684 bp (pEGFP-N2).
Atomic Force Microscopy (AFM)
Prior to AFM measurements, carriers were added to the
DNA solutions in 1:1 carrier-to-DNA weight ratios, and
allowed to incubate for 20 min at room temperature. The
solutions were diluted ×100 with ddH2O and 1.5 µL of the
resulting solution was deposited onto freshly cleaved
mica surfaces. Samples were allowed to dry in air for 20
min or until water had visibly evaporated from the sur-
faces. Experiments were performed with MFP-3D-BIO
(Asylum Research; Santa Barbara, CA) operating in tap-
ping mode (AC) using standard silicon cantilever
(AC240TS) with ~2 N/m spring constant and 70 KHz
Structure of the DNA molecules used in this study Figure 1
Structure of the DNA molecules used in this study. A. Structure of the parent c-DNA. B. l-DNA formed by restriction digest 
of c-DNA with the enzyme XhoI. The size of the linearized plasmid was 4272 bp, C. pcr-DNA (2209 bp) generated by site-spe-
cific primers that amplified the region of the c-DNA containing the HTLV promoter, the hOPG open reading frame, and the 
SV40 Poly-A site. D. Structure of the parent c-DNA used in transfection. E. l-DNA formed by digest of pEGFP-N2 with the 
enzyme ClaI, which cuts in the vector backbone. F. pcr-DNA (1713 bp) generated by primers that are complementary to the 
sequence upstream of the CMV promoter and downstream of the polyA site.
A.
B.
C.
D.
E.
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working frequency. All images were recorded in air at
room temperature inside an acoustic enclosure, and on a
vibration isolation table at a scan speed of 1 Hz.
Particle Size Measurement
The diameter of the particles formed by carrier/DNA com-
plexes was measured by photon correlation spectroscopy
(ZetaPALS, Brookhaven Instruments, Holtzville, NY).
Four microgram of DNA was complexed with the appro-
priate volume of polymer solution at a carrier/DNA
weight ratios of 5, 7.5 and 10 in a total volume of 50 µL
diluted with 150 mM NaCl. The complexes were left to
stand at room temperature for 30 minutes, then diluted to
2 mL with DMEM and incubated for another 30 minutes
before analysis. The measurement time was set at 30 sec-
onds intervals and each run consisted of 10 consecutive
measurements (SD among the measurements was typi-
cally ~1%). Particle sizes were measured at a wavelength
of 660 nm and calculated by using a medium viscosity of
1.140 cP [11] and a refractive index of 1.333 (at 25°C).
Electrophoretic Gel Mobility Assay (EMSA)
Electrophoretic mobility of carrier/DNA solutions was
performed by loading the complexes (see preparation
condition below) into a 0.7-0.8% agarose gel containing
1 µg/mL of Ethidium Bromide in 1× Tris-Acetate/EDTA
buffer. The agarose gel was run with 115 V of current for
~20 min and the DNA bands were visualized using the
Alpha Imager (Alpha Innotech; San Leandro, CA). Mean
fluorescent density (in arbitrary units) of each band was
measured by the manufacturer-supplied software.
Analysis of Carrier-DNA Binding
200 ng of DNA was first suspended in 100 mM HEPES
buffer (pH 5.2), carriers were then added to DNA solu-
tions at DNA:carrier weight ratios of 2, 1, 0.5, 0.2, 0.1, and
0 in a final volume of 15 µL, and the solutions were
allowed to incubate at room temperature for 30 min. The
samples were then loaded into the gel as described above.
The amount of free DNA in each lane was quantitated by
densitometric analysis. The percentage of DNA bound was
calculated from the fluorescent density (F) values as: %
DNA bound = {F(DNA only) - F(specific DNA-polymer
ratio)} ÷ {F(DNA only) - F(background)}•100%. %DNA
bound vs. carrier:DNA ratios were plotted, and used to
obtain a carrier/DNA-specific IC50 value, indicating the
carrier:DNA ratio that gave binding to 50% of the DNA in
the sample.
Analysis of Carrier-DNA Complex Dissociation
350 ng of DNA molecules in 150 mM NaCl were com-
plexed with 3 µg of polymer in a final volume of 10 µL for
30 min at room temperature. Then, 10 µL of either basic
medium (with 10% FBS) or 10 µL of DMEM was added to
the samples, and incubated at room temperature for an
additional 1.5 hours. Heparin sulfate were then added at
a final concentration range of 0.02-32 µg/mL and the
samples were incubated for 30 min. The samples were
then loaded onto the gel and visualized as described
above. The percentage of DNA dissociated was calculated
from the fluorescent density (F) values as: %DNA released
= {F(specific heparin concentration) - F(background)} ÷
{F(DNA only) - F(background)}•100%.
Cell Culture and DNA Uptake
Rat bone marrow stromal cells (rBMSC) were isolated and
cultured as described previously [12]. Briefly, cells were
isolated from both femurs of 8-week old female Sprague-
Dawley rats and pooled to obtain a single suspension. The
bone marrow was flushed out with 15 mL of DMEM con-
taining 10% FBS, 50 µg/mL ascorbic acid, 100 U/mL Pen-
icillin and 100 µg/L of Streptomycin (referred to hereon as
basic medium). Cells were centrifuged for 6 min at 600
rpm, suspended in fresh basic medium and seeded in a
single 75 cm2  flask (Sarstedt; Montreal, QC). After
medium change on day 3, the cells were trypsinized on
day 7 and expanded in 75 cm2 flasks (1:4 dilution). The
rBMSC passaged between 2-4 generations were used in
this study, and were grown in multiwell plates for DNA
uptake studies.
To investigate DNA uptake, 20 µg of DNA was labeled
with Cy5.5-NHS as suggested by manufacturer's protocol.
Labeling reaction was stopped by the addition 100 mM
Tris-Cl to quench the pre-activated succinimide ester moi-
ety. Labeled DNA was dialyzed against 10 mM Tris-Cl (pH
7.4) then again with ddH2O. The samples for uptake were
prepared with 5 µL of the labeled DNA solution added to
2, 6 or 18 µg of the polymer (0.3, 1 and 3 µg for branched
PEI) in a final volume of 40 µL. The samples were added
directly to the rBMSC grown in 6-well plates with 2 mL of
basic medium. Each polymer concentration was typically
tested in duplicates. Cells are incubated for 24 hours at
37°C (5% CO2), after which they were washed with HBSS
(x2), trypsinized for 5 min for detachment and suspended
in HBSS with 4% formalin. Fluorescence was measured at
λem  = 690 nm and λem  = 705 nm. The results were
expressed as the percentage of cells exhibiting significant
fluorescence over that of control samples (i.e. cells
exposed to DNA with no polymer), which was set to ~1%
uptake. In same cases, the uptake was expressed as the
average fluorescence exhibited in cells (in arbitrary units).
Transfection and Assessment of EGFP Expression
Two cell types were used for assessment of transgene
expression, primary rBMSC and immortalized HEK 293T
cells. BMSC were cultured and maintained as described in
the DNA uptake studies. HEK 293T cells were seeded in
12-well tissue culture plates supplemented with DMEM
media containing 10% FBS. When cells reached ~80%BMC Biotechnology 2008, 8:23 http://www.biomedcentral.com/1472-6750/8/23
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confluency, they were transfected with PEI/DNA com-
plexes prepared at a polymer/DNA weight ratio of 2.5
(PEI:DNA concentration of 5:2 µg/mL in tissue culture
medium). Complexes were incubated at room tempera-
ture for 25 minutes then added directly to cells covered in
a basic medium. The cells were allowed to incubate at
37°C in the presence of complexes for 24 h followed by
replacement of 1 mL of DMEM containing 10% FBS.
Transfected 293 cells were either processed for flow
cytometry following complex removal (24 hours), or
incubated for another 72 hours before assessment of
EGFP expression by flow cytometry. BMSC were processed
48 hours after complexes were removed. Flow cytometry
was performed on a Cell Quanta SC with MPL Option
(Beckman Coulter) where the EGFP fluorescence was
detected in the FL1 channel. The instrument settings were
calibrated for each run so as to obtain a background level
of EGFP expression of ~1% for control cells. The latter
included (i) cells treated with 2 µg/mL of c-DNA, l-DNA
and pcr-DNA without any carriers, and (ii) cells treated
with PEI/gWiz-blank plasmid that contained no func-
tional genes (to ensure that internalized complexes do not
provide a non-specific fluorescence in flow cytometry).
Statistical Analysis
Where indicated, all results are summarized as mean ±
standard deviation, and statistical variations (p < 0.05)
between the group means were analyzed by the Student's
t-test.
Results
Particle Formation
The three DNA molecules were mixed with various gene
carriers in solution to examine particle formation and
morphology (Figure 2). When DNA molecules were
examined under AFM in the absence of carriers, a network
of interconnecting fibrous strands was observed, espe-
cially for c-DNA (Figure 2a) and l-DNA (Figure 2f),
whereas pcr-DNA appeared as discontinuous strands (Fig-
ure 2k). When branched PEI was added to the DNA solu-
tions (Figure 2b, 2g, and 2l), spherical particles were
observed for all three types of DNA molecules with no evi-
dence of string-like DNA molecules. The sizes of the parti-
cles ranged from ~40 nm to ~180 nm in diameter, and
were independent of the type of DNA molecules used.
Similar observation was noted for particles obtained with
PLL (Figure 2c, 2h, and 2m) and PLL-PA (Figure 2d, 2i and
2n). The sizes of the particles formed by the PLL and PLL-
PA were equivalent to those formed by the branched PEI.
The cationic lipid, Lipofectamine-2000™, also bound and
condensed c-DNA and l-DNA into spherical particles (Fig-
ure 2e and 2j). However, the sizes of some of the particles
were significantly larger, with some particles being as large
as ~450 nm. Some particles were observed when pcr-DNA
were mixed with Lipofectamine-2000™ (Figure 2o), but
isolated islands of presumably Lipofectamine-2000™
formed over the mica surface covering some of the DNA
molecules. Although we followed the manufacturer's
instructions for DNA condensation in the latter case,
excess lipid was apparently present in these solutions. At
the same time, some string-like structures, reminiscent of
naked pcr-DNA, were also seen in these samples, suggest-
ing incomplete condensation of pcr-DNA molecules with
the Lipofectamine-2000™. Taken together, all of the gene
carriers examined was able to condense the c-DNA, l-DNA
and pcr-DNA molecules into spherical particles, except
the Lipofectamine-2000™/pcr-DNA combination, which
gave incomplete condensation of the DNA molecules.
The particle sizes were additionally analyzed by dynamic
light scattering (Table 1). Unlike AFM, this method char-
acterizes the size of the particles in solution and it can be
considered more representative of the state of the particles
in contact with the cells. Three different carrier:DNA ratios
were used to investigate its effect on particle sizes.
Whereas some combinations (e.g., PLL-PA and PEI com-
bined with c-DNA) gave the expected decrease in size with
increasing carrier:DNA ratio, other combinations (e.g.,
ones involving l-DNA and Lipofectamine-2000™) did not
give a predictable pattern. Particles from Lipofectamine-
2000™ were generally larger for each DNA molecule, and,
in some cases, no stable measurements could be taken
either due to visible precipitation of the complex solution
or formation of large particle aggregates. This was consist-
ent with the AFM observations on Lipofectamine-2000™
complexed DNA molecules. With PLL-PA, l-DNA gave rel-
atively larger particles (~350 nm) as compared to c-DNA
and pcr-DNA (100-160 nm). This was the case with PEI as
well, except PEI complexes appeared to be significantly
larger than the PLL-PA complexed particles for each type
of DNA molecule.
DNA Binding
Figure 3 shows the results of the densitometric analysis
from the EMSA assay intended for semi-quantitative anal-
ysis of DNA-carrier interactions. For each carriers exam-
ined, there was no significant difference in the binding
interaction among the DNA molecules; i.e., the curve indi-
cating percent bound vs. carrier:DNA ratio overlapped for
all three DNA molecules. However, the carrier:DNA ratios
necessary for complete (100%) binding and for IC50 were
different among the carriers. Complete binding were
achieved at ~0.5, ~1.0, ~1.0, and ~3.0 carrier:DNA ratios
for branched PEI, PLL, PLL-PA, and Lipofectamine-2000™,
respectively (Figure 3a, 3b, 3c, and 3d). The IC50 values
were ~0.15, ~0.45, ~0.3, and ~1.2 for branched PEI, PLL,
PLL-PA, and Lipofectamine-2000™, respectively.BMC Biotechnology 2008, 8:23 http://www.biomedcentral.com/1472-6750/8/23
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Complex Dissociation
The dissociation of DNA/carrier complexes was investi-
gated by incubating heparin sulfate with the complexes.
The dissociation was conducted in complete culture
medium to mimic the conditions while the complexes are
incubated with the cells. Heparin was able to dissociate
the complexes for all carriers (Figure 4), based on the lib-
eration of free DNA molecules upon incubation with the
highest heparin concentration. With branched PEI, the
dissociation of the complexes as a function of heparin
concentration was similar for all three DNA molecules
(Figure 4a), where >80% dissociation of the complexes
was observed at the highest heparin concentrations. This
was the case for PLL as well (Figure 4b), except the extent
of dissociation was generally less than 80%. With PLL-PA
and Lipofectamine-2000™, c-DNA gave a relatively lower
heparin-induced dissociation as compared to l-DNA and
pcr-DNA (Figure 4c and 4d, respectively) and, in both
cases, it was not possible to release more than 50% of the
c-DNA.
DNA Delivery to rBMSC
The intracellular DNA delivery was investigated by using
DNA molecules fluorescently labeled with Cy5.5 fluoro-
phore. Figure 5 shows the results of Cy5.5-labeled DNA
uptake by BMSC grown in basic medium, which were car-
ried out with a fixed concentration of DNA and varying
concentrations of the carriers. In all cases, the cellular
delivery increased with increasing carrier concentration in
Tapping mode atomic force microscope amplitude topography of the three DNA molecules complexed with various gene car- riers Figure 2
Tapping mode atomic force microscope amplitude topography of the three DNA molecules complexed with various gene car-
riers. All images were captured at a scan size of 6 × 6 µm, except where noted. c-DNA without carriers [8 × 8 µm] (a), with 
PEI (b), PLL (c), PLL-PA (d), and Lipofectamine-2000™ (e). l-DNA without carriers (f), with PEI (g), PLL (h), PLL-PA (i), and 
Lipofectamine2000™ (j). pcr-DNA without carriers [5 × 5 µm] (k), with PEI (l), PLL (m), PLL-PA (n), and Lipofectamine-
2000™ (o).
a
f
k
g
l
b c d e
h i j
m n o
No carrier PEI PLL PLL-PA Lipofectamine
c-DNA
l-DNA
pcr-DNA
Table 1: Mean particle sizes (nm) obtained for the DNA 
molecules at three (5.0, 7.5 and 10.0) carrier:DNA mass ratios. 
The values shown are usually derived form the average of 2 
measurements, and SD between the measurements was <5% 
(not shown). NS: No stable measurements were taken for these 
samples. The zeta potential of the particles were >30 mV in all 
cases (not shown).
Circular DNA Linear DNA PCR DNA
5.0 7.5 10.0 5.0 7.5 10.0 5.0 7.5 10.0
PEI 337 188 159 735 710 772 518 414 273
PLL-PA 169 124 106 354 388 338 104 99 103
Lipo 758 964 1002 NS 1406 421 NS NS NSBMC Biotechnology 2008, 8:23 http://www.biomedcentral.com/1472-6750/8/23
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the formulations. The percentages of Cy5.5-positive cells
were generally highest when branched PEI and PLL-PA
were used as the carriers. Branched PEI was able to deliver
all three types of DNA molecules up to ~80% of the cells
at a lower polymer concentration as compared to the PLL-
PA (~1.5 µg/mL vs. ~3.0 µg/mL; Figure 5a and 5c, respec-
tively). PLL did not give any elevated level of DNA uptake
in comparison to cells exposed to their respective DNA
controls (Figure 5b). Lipofectamine-2000™ had a maxi-
mum of ~20% of Cy5.5-positive cells at the highest con-
centration tested (9 µg/ml; Figure 5d). For each carrier,
there were no apparent differences in the delivery effi-
ciency among the three DNA molecules.
Effect of Serum on DNA Delivery
Several studies have shown serum in culture medium to
influence gene delivery by non-viral gene carriers [13,14].
To investigate whether serum had an effect on delivery of
different DNA molecules, complexes were incubated with
the cells for 4 and 24 hours in the presence (10% serum)
and absence of serum. Branched PEI and PLL-PA again
gave the highest extend of DNA delivery (Figure 6a and 6c,
respectively), with PLL giving the lowest delivery of DNA
to the cells (Figure 6b), similar to the results shown in Fig-
ure 5. With branched PEI (Figure 6a), the extent of DNA
delivery among the three DNA molecules was similar (70-
90%). The presence of serum did not have a major effect
on DNA delivery, except at the early time point (4 hour)
for pcr-DNA, where the uptake appeared to increase by
~31% in the absence of serum. With PLL-PA as the carrier
(Figure 6c), the extent of DNA delivery reached saturation
(~100% of rBMSC) for the three types of DNA molecules
in the absence of serum. However, l-DNA and pcr-DNA
gave lower delivery at earlier time point (4 hour) in the
presence of serum (~64% and ~37% reduction, respec-
tively). With Lipofectamine-2000™ as the carrier (Figure
6d), the extent of delivery was low in the presence of
serum (~20%) for all DNA molecules. In the absence of
serum, DNA uptake after 24 hours was ~2-fold higher for
all three DNA molecules.
The average fluorescence of Cy5.5-positive cells after incu-
bation with complexes is also shown in Figure 6. These
fluorescent values were used as a quantitative measure of
Analysis of DNA binding to the gene carriers PEI (a), PLL (b), PLL-PA (c), and Lipofectamine-2000™ (d) Figure 3
Analysis of DNA binding to the gene carriers PEI (a), PLL (b), PLL-PA (c), and Lipofectamine-2000™ (d). Densitometric anal-
yses of the binding results in the form of percent DNA bound were summarized as a function of increasing carrier:DNA weight 
ratio. The corresponding gel pictures of DNA-carrier complex were also shown.
a. PEI b. PLL
c. PLL-PA d. Lipofectamine
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the amount of DNA internalized by the rBMSC. Consist-
ent with the percent uptake results, the highest DNA deliv-
ery was obtained with the branched PEI and PLL-PA as the
carriers. With branched PEI, there was a ~2-fold increase
(p < 0.01) in DNA delivery from 4 to 24 hour time point
(Figure 6a). Neither serum nor the type of DNA molecules
had an effect on the amount of Cy5.5-labeled DNA being
internalized by the cells. When PLL was used as the carrier,
the amount of internalized Cy5.5-labeled DNA was low;
there was no effect of the serum or the type of DNA mol-
ecules on the DNA delivery (Figure 6b). With PLL-PA as
the carrier, ~2-fold increase in the DNA uptake was again
observed upon incubation of the complexes with the cells
from 4 to 24 hours (Figure 6c). In this case, approximately
Dissociation kinetics of DNA-carrier complexes using heparin sulfate as the competitive polyanion Figure 4
Dissociation kinetics of DNA-carrier complexes using heparin sulfate as the competitive polyanion. Results are displayed as a 
function of the concentration of heparin added and the percent of DNA released. Shown here are dissociation of the com-
plexes with PEI (a), PLL (b), PLL-PA (c), and Lipofectamine-2000™ (d).
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2.3-3.7 fold increase in DNA delivery was observed in the
absence of serum with all three types of DNA molecules.
With Lipofectamine-2000™, an increase in DNA delivery
was also observed under longer incubation time (4 vs. 24
hours, Figure 6d). Eliminating serum gave a significant
increase in DNA delivery for all three types of DNA mole-
cules at the 24-hour time point.
Transgene Expression
Assessment of gene expression was carried out by using
the reporter gene EGFP, rather than the OPG plasmid pre-
viously used, since quantitating the extent of gene expres-
sion could be readily assessed by flow cytometry.
Preliminary studies using pEGFP-N2 with PLL, PLL-PA,
Lipofectamine-2000™ and PEI indicated the PEI to be the
most effective carrier in our set up (data not shown).
Delivery of c-DNA, l-DNA and pcr-DNA into rBMSC using PEI (a), PLL (b), PLL-PA (c), and Lipofectamine-2000™ (d) at var- ious concentrations of carriers Figure 5
Delivery of c-DNA, l-DNA and pcr-DNA into rBMSC using PEI (a), PLL (b), PLL-PA (c), and Lipofectamine-2000™ (d) at var-
ious concentrations of carriers. The cells were grown in 6-well plates for 24 hours, and incubated with carrier/DNA com-
plexes for an additional 24 hours. Results from the flow cytometry were expressed as percentages of cells positive for Cy5.5-
fluorescence, where the cells incubated with DNA alone (i.e., without any carrier) was calibrated at ~1%.
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DNA delivery by PEI (a and e), PLL (b and f), PLL-PA (c and g), and Lipofectamine-2000™ (d and h) in the presence and  absence of serum Figure 6
DNA delivery by PEI (a and e), PLL (b and f), PLL-PA (c and g), and Lipofectamine-2000™ (d and h) in the presence and 
absence of serum. The cells were grown in 24-well plates for 24 hours, and incubated with carrier/DNA complexes for an 
additional 4 and 24 hours. Results from the flow cytometry were expressed either as percentages of cells positive for Cy5.5-
fluorescence (a, b, c and d) or mean fluorescence for Cy5.5-positive cells (e, f, g and h). Statistical differences between the 
medium with and without serum are indicated above: *p < 0.05, **<0.025, ***p < 0.01 and ****p < 0.001.
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Therefore, subsequent expression studies were performed
by using PEI as the sole carrier and the three types of DNA
molecules to specifically focus on the relative effectiveness
of each DNA molecule for the expression of reporter gene
(rather than focusing on the effectiveness of each carrier).
To determine if the enzymatic manipulations used to gen-
erate the l-DNA and pcr-DNA yielded functional gene
constructs, transfections were initially carried out in HEK
293 T cells since they are considered to be a readily-trans-
fectable cell phenotype. The results obtained from these
cells are summarized in Figure 7. The c-DNA was the most
effective form of DNA based of percentage of EGFP-posi-
tive cells (Figure 7a), giving ~90% cells with EGFP expres-
sion on Day 1. Transfection efficiency using l-DNA and
pcr-DNA were significantly lower: ~61% and ~48% EGFP-
positive cells, respectively. On Day 4, the percentage of
EGFP-positive cells was reduced for c-DNA and l-DNA
(but not pcr-DNA) transfected cells as compared to Day 1.
The relative mean fluorescence values of the EGFP-posi-
tive cells (Figure 7b) were used as a measure of extent of
EGFP expression; the c-DNA transfected cells displayed
~3.5 and ~2.5 fold increase in mean fluorescence over l-
DNA and pcr-DNA transfected cells, respectively (Day 4).
Non-treated cells, as well as the cells exposed to the three
forms of DNA alone (i.e., without any carrier) gave results
similar to the cells treated with PEI/gWiz complexes (not
shown).
Transfection efficiency of c-DNA, l-DNA, and pcr-DNA using PEI as the gene carrier in HEK 293T Cells (A and B) and rBMSC  (C and D) Figure 7
Transfection efficiency of c-DNA, l-DNA, and pcr-DNA using PEI as the gene carrier in HEK 293T Cells (A and B) and rBMSC 
(C and D). Cells were grown in 12-well plates and incubated with the complexes for 24 hours. EGFP expression was assessed 
on Day 1 and 4 for 293 cells, and on Day 3 for rBMSC. Results from the flow cytometry were expressed as either (i) percent-
age of EGFP-positive cells, when control cells were assigned to ~1% EGFP-positive cells (A and C), or (ii) the relative fluores-
cence values for EGFP-positive cells (B and D). The control cells in both cases were the cells exposed to PEI/gWiz-blank 
complexes without the EGFP gene. In the case of 293 cells, the relative fluorescence for the EGFP-positive cells was normal-
ized with the fluorescence values for control cells to account for the day-to-day differences. For rBMSC, the mean fluores-
cence values were shown without normalization.
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Using complexes similar to the ones used on 293 cells,
transfection efficiency of rBMSC was found to be much
lower; control cells exposed to PEI/gWiz complexes with-
out an EGFP gene gave ~1.5% EGFP-positive cells as a
background (Figure 7c), which was similar to values
obtained with non-treated cells, and cells exposed to the
three DNA molecules without any carrier (~1%; not
shown). rBMSC transfected with complexes containing a
functional EGFP gene afforded only 2-3% EGFP-positive
cells (Figure 7c). There was no significant difference in the
percent of GFP-positive cells between c-DNA and l-DNA;
however, both forms of DNA were significantly more
effective than pcr-DNA (p < 0.05). Among the EGFP-pos-
itive cells, the mean fluorescence values for all three DNA
molecules were significantly greater than the control cells
(Figure 7d). The cell treated with c-DNA had a greater
mean fluorescence than the cells treated with l-DNA (p <
0.05), and both c-DNA and l-DNA gave a significantly (p
< 0.05) greater mean fluorescence values than the pcr-
DNA.
Discussion
Non-viral gene delivery systems employ cationic poly-
mers or lipids as vectors for delivery of therapeutic genes
into pertinent cells. Previous studies have examined the
effects of DNA molecular weight and topology on trans-
fection efficiency [6,8] but failed to study the intracellular
delivery of different DNA molecules per se. We employed
three types of cationic polymers and one cationic lipid to
determine if common non-viral gene carriers would have
the same delivery efficacy using different physical forms of
DNA. To compare the effects of physical properties alone
on cellular uptake, all DNA molecules were manipulated
from a single source of circular plasmid DNA extracted
from bacteria. l-DNA and pcr-DNA were prepared by
restriction digest and PCR, respectively, using c-DNA as
the source or the template. The procedures were opti-
mized to obtain homogenous products without gel elec-
trophoresis. It is known that EtBr/UV light combination
damages DNA by inducing strand breakage and oxidation
[15,16]. To avoid this potential artifact, all DNA prepara-
tions have been performed in the absence of EtBr.
The ability of gene carriers to bind DNA and condense the
molecule into particles is assessed qualitatively by AFM
and quantitatively by photon correlation spectroscopy.
AFM assessment indicated that the cationic polymers were
able to condense all three types of DNA molecules into
spherical particles with no discernible morphological dif-
ferences. A variation in particle sizes was evident for indi-
vidual carriers in AFM measurements, but size ranges
appeared to overlap between the types of DNA molecules.
Photon correlation spectroscopy indicated the PEI com-
plexed DNA to be larger than the PLL-PA particles. The
smaller size of the particles obtained from AFM is not sur-
prising, considering that they were obtained under 'dry'
condition which is likely to represent a collapsed state of
the particles. The type of DNA molecule was a determin-
ing factor in the sizes of particles formed with the poly-
meric carriers (Table 1). Lipofectamine-2000™ also
condensed DNA into spherical particles for both c-DNA
and l-DNA, and the particles were similar in size to those
observed elsewhere [17]. However, full condensation did
not occur for the pcr-DNA at the weight ratios used in this
experimental set-up. This was also the case for these parti-
cles from photon correlation spectroscopy measurements.
Based on semi-quantitative EMSA analysis [18], no signif-
icant differences in the binding interaction among the
three types of DNA molecules was evident for each carrier.
Branched PEI was able to completely condense DNA at
lower polymer-to-DNA weight ratio compared to other
carriers. Both PLL and PLL-PA were able to completely
condense DNA at the same ratio, however, the modifica-
tion of PLL with palmitic acid led to an increase in bind-
ing affinity, contrary to the observation reported earlier
[10]. The combination of AFM and EMSA results pointed
to no apparent differences between the DNA molecules
and their interaction with the carriers. It was interesting to
note that EMSA results (indicating 100% binding at car-
rier:DNA ratios of ≤1), were mostly consistent with the
AFM results, which indicated no free DNA at the car-
rier:DNA ratio of 1. The only exception was the results
from Lipofectamine-2000™, where complete binding was
seen at the carrier:DNA ratios of ~3, whereas AFM indi-
cated no free DNA (for c-DNA and l-DNA) at the ratio of
1. It was possible that Lipofectamine-2000™ complexa-
tion led to more fragile particles that did not withstand
the electrophoretic forces under EMSA assay conditions.
Dissociation of DNA from gene carriers is essential for
efficient gene expression because access by the transcrip-
tion machinery requires free and intact DNA [19,20]. The
dissociation characteristics of the complexes were studied
using heparin sulfate as a competitive polyanion to dis-
rupt the interaction between the carriers and DNA mole-
cules. Heparin sulfate is an anionic polysaccharide known
to be a major component of extracellular matrix, and have
been shown to inhibit DNA delivery [21-23]. It was used
here to mimic the conditions that particles encounter
under cell culture conditions. For DNA complexes formed
with PEI and PLL, there was no significant difference in
the dissociation profile among the three types of DNA
molecules. With both vectors, however, DNA could not be
fully dissociated from the complex. This may be due to a
rate-dependent reorganization process that takes place
after the initial complexes were formed, leading to a
'mature' complex with stronger electrostatic interaction
that cannot be easily disrupted [19]. Complexes of PLL-PA
and Lipofectamine-2000™ showed a different dissociation
profile among the three types of DNA, where linear formsBMC Biotechnology 2008, 8:23 http://www.biomedcentral.com/1472-6750/8/23
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of DNA molecules were dissociated to a greater extent
than the c-DNA. This suggested that a similar maturation
process exist for the lipoplexes [24], and the extent of mat-
uration varied among the different topologies of DNA.
Grafting of the fatty acid palmitic acid on PLL renders a
partial lipophilic characteristic to the cationic polymer,
and is likely to account for the similarity in the dissocia-
tion profile to that of Lipofectamine-2000™, that is, with
c-DNA being the least dissociated. Overall, our results sug-
gested a similar efficiency in the unpacking of vector (dis-
sociation) among the three DNA molecules for the
polymeric carriers, but not for the lipid-based carriers
whose dissociation was stronger with l-DNA molecules.
Since expression of the transgene (OPG) was not explored
in this study, it remains to be determined whether such a
difference in dissociation would ultimately lead to differ-
ences in expression efficiency for different DNA isoforms.
With respect to DNA delivery to the cells, we observed no
major difference in the level of DNA uptake among the
three physical forms of DNA molecules. This was the case
despite the fact that average particle sizes were found to
depend on the nature of the DNA molecule. It is possible
that significant variations in particle sizes in each complex
preparation might have masked such a possible effect.
Different routes of entry (i.e., clathrin- vs. caveolae-medi-
ated) could also have been utilized by different complexes
[25], but our studies were not designed to probe these dif-
ferences. It must be pointed out that serum could not be
used during photon correlation spectroscopy due to
unstable readings obtained. Any changes in particle sizes
in the presence of serum [26,27] might complicate our
understanding of size effects on the DNA delivery. How-
ever, there was a difference in the delivery efficiency of
DNA among the carriers. PEI was able to deliver DNA to
cells at much lower concentrations and was the most
effective carrier of the four examined. PLL was the least
effective carrier for DNA uptake and its performance was
comparable to when no carrier was used. In previous stud-
ies, PLL was shown to be readily taken up by the cells [28]
but it appeared that its ability to carry a DNA cargo was
relatively low. This is in contrast to the results obtained in
other studies when fluorescent microscopy was used to
detect DNA uptake [28]. The low level of uptake observed
in this study may be attributed to the low sensitivity of the
flowcytometer or a high cut-off level set up with the con-
trol samples (i.e. no carrier). There was no apparent corre-
lation between particle formation, polymer-DNA
interaction, complex dissociation and the DNA uptake.
For example, PLL, despite showing typical DNA binding
and dissociation activity, did not enable an equivalent
DNA level of delivery into cells when compared to other
carriers. This conclusion was valid for all three DNA mol-
ecules used in this study.
The presence of serum during cellular internalization of
complexes did not influence the uptake of complexes of
pure cationic carriers PEI and PLL, but did influence deliv-
ery by the lipophilic Lipofectamine-2000™ and PLL-PA.
This may be due to serum inhibition of the complex mat-
uration process, resulting in reduced uptake [24]. The fact
that 24-hour uptake was still influenced by the presence of
serum suggested the maturation process to last through-
out this time period. Serum has previously been described
to inhibit lipofection [29] as well as DNA uptake of lipo-
plexes [30,31]. For PLL-PA, only the linear forms of the
DNA were affected by the serum. Given its partial
lipophilic characteristic, the difference in the level of
uptake may be directly related to the rate of complex mat-
uration mentioned earlier. The observation that l-DNA is
affected to a greater extent than pcr-DNA may be attrib-
uted to size differences between the molecules. Larger l-
DNA was expected to take longer to reorganize itself into
the matured complex; this may cause it to become more
susceptible to binding by serum proteins than smaller l-
DNA. All polymers resulted in an increase in absolute
amount of DNA delivery from 4 to 24 hours, suggesting
that the uptake pathway is a rate-limiting process for these
carriers. Furthermore, PLL-PA showed a significant
increase in absolute amount of DNA delivery in the
absence of serum, where a similar increase was absent in
Lipofectamine-2000™. Serum thereby affected PLL-PA dif-
ferently than the Lipofectamine-2000™. The difference in
the degree of sensitivity to serum can be accounted for by
the nature of the lipid groups (monovalent vs. multiva-
lent) [24], in addition to the polymeric nature of PLL-PA,
which contributed to the continued uptake of complexes
in the absence of serum.
The transfection results from both 293 cells and rBMSC
showed that the supercoiled circular plasmid DNA was
more effective topology for transfection than its linearized
equivalent of the same molecular weight. This observa-
tion was consistent with previous reports [5,32]. Remaut
et al. [5] attributed better translocation of c-DNA to peri-
nuclear regions for better transgene expression by the c-
DNA. We have further investigated the effectiveness of a
gene cassette, which is approximately half the size of the
linearized plasmid DNA; pcr-DNA was even less effective
than l-DNA, even though the number of gene-encoding
templates was expected to be twice that of l-DNA or c-
DNA (per unit mass basis exposed to the cells). The car-
rier-DNA interactions (either binding or dissociation)
were not expected to be different between the l-DNA and
pcr-DNA at a given carrier:DNA ratio, as well as the uptake
into the cells (data from Figures 3, 4 and 5). Thus, the dif-
ference in transfection efficiency between l-DNA and pcr-
DNA cannot be explained from these considerations. The
only difference between these two DNA molecules was in
the hydrodynamic diameter of the complexes, where pcr-BMC Biotechnology 2008, 8:23 http://www.biomedcentral.com/1472-6750/8/23
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DNA gave smaller particles compared to l-DNA, but our
data on this issue is too limited to probe a correlation
between transfection and complex size. The difference
observed in transfection could be attributed to intracellu-
lar response to the DNA itself. Several factors might come
into play, including; (i) different rates of intracellular deg-
radation of the DNAs (the smaller pcr-DNA could be
more sensitive to degradation due to lower content of
ectopic sites), and (ii) ease of accessibility of the template
to transcription factors (the promoter of the smaller pcr-
DNA might be more effectively blocked with the carrier as
compared to the longer l-DNA). It is also possible that dif-
ferent types of DNA molecules would elicit different met-
abolic responses. For example, double-stranded l-DNA
and pcr-DNA have exposed 5'-phosphate groups on their
ends, which resemble damaged DNA. When introduced
into cells, these DNA molecules might cause an inhibition
of overall gene expression as a protection mechanism
against aberrant expression, effectively reducing transgene
efficiency. Still other factors may come into play, but this
study was not intended to explore the intracellular fate
and consequences of exogenous DNA delivery. Further
studies on these issues will be conducted in the future to
explain the difference in transfection efficiency among dif-
ferent DNA molecules.
Conclusion
In conclusion, this study aimed at evaluating the delivery
of different sizes and topologies of DNA by non-viral car-
riers. We have shown that there were no discernible differ-
ences in either the in vitro binding interaction to the gene
carriers or the efficiency of uptake between either the cir-
cular and linear forms or between large and small DNA
molecules. There was some effect on uptake and complex
interaction in the presence of serum, but this difference
was mostly influenced by the nature of the carrier itself,
rather than the inherent properties of the DNA molecules.
With the chosen PEI carrier, c-DNA was found to be more
effective than the linearized DNA molecules for transgene
expression. Better delivery of c-DNA into the cells was not
the reason for its better performance, since the chosen car-
rier was able to efficiently deliver all DNA molecules into
the cells regardless of their sizes and topologies. Intracel-
lular processing of the DNA molecules was more likely to
be the underlying reason for better efficiency of c-DNA.
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